Fund profile
Tickers
FBDIX, FTDZX, FRBRX, FBTDX
Fund manager
Total assets
$885.55 mm
Liabilities
$10.76 mm
Net assets
$874.79 mm
Number of holdings
101.00
101 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
AMGN AMGEN Inc. | 61.97 mm | 226.21 k shares | 7.08 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 55.42 mm | 62.22 k shares | 6.34 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 46.75 mm | 119.03 k shares | 5.34 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 35.27 mm | 254.77 k shares | 4.03 | Common equity | Long | Denmark |
AstraZeneca plc
|
30.07 mm | 396.31 k shares | 3.44 | Common equity | Long | UK |
BIIB Biogen Inc | 27.79 mm | 129.34 k shares | 3.18 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 26.34 mm | 404.04 k shares | 3.01 | Common equity | Long | USA |
Institutional Fiduciary Trust - Money Market Portfolio | 25.97 mm | 25.97 mm shares | 2.97 | Short-term investment vehicle | Long | USA |
ITCI Intra-Cellular Therapies Inc | 25.51 mm | 355.21 k shares | 2.92 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 22.92 mm | 166.63 k shares | 2.62 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 22.89 mm | 354.37 k shares | 2.62 | Common equity | Long | USA |
Jazz Pharmaceuticals plc
|
22.58 mm | 203.86 k shares | 2.58 | Common equity | Long | Ireland |
Merus NV
|
22.44 mm | 499.70 k shares | 2.57 | Common equity | Long | Netherlands |
CGEM Cullinan Therapeutics Inc | 16.87 mm | 624.45 k shares | 1.93 | Common equity | Long | USA |
ARGX Argen X SE | 16.70 mm | 44.49 k shares | 1.91 | Common equity | Long | Netherlands |
PTCT PTC Therapeutics Inc | 15.45 mm | 480.61 k shares | 1.77 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 14.82 mm | 866.38 k shares | 1.69 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals Inc | 14.62 mm | 830.63 k shares | 1.67 | Common equity | Long | USA |
ILMN Illumina Inc | 13.14 mm | 106.79 k shares | 1.50 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics Inc | 12.69 mm | 1.53 mm shares | 1.45 | Common equity | Long | USA |
INSM Insmed Inc | 12.23 mm | 494.94 k shares | 1.40 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 11.73 mm | 193.74 k shares | 1.34 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 11.40 mm | 202.15 k shares | 1.30 | Common equity | Long | USA |
APLT Applied Therapeutics Inc | 10.79 mm | 2.44 mm shares | 1.23 | Common equity | Long | USA |
APGE Apogee Therapeutics Inc. | 10.39 mm | 206.54 k shares | 1.19 | Common equity | Long | USA |
ACHV Achieve Life Sciences Inc. | 9.57 mm | 2.18 mm shares | 1.09 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 9.57 mm | 75.55 k shares | 1.09 | Common equity | Long | USA |
AVTR Avantor Inc. | 9.30 mm | 383.93 k shares | 1.06 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 9.00 mm | 355.43 k shares | 1.03 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals Inc | 8.88 mm | 1.02 mm shares | 1.02 | Common equity | Long | USA |
HLVX HilleVax Inc | 8.53 mm | 646.16 k shares | 0.98 | Common equity | Long | USA |
IMVT Immunovant Inc | 8.18 mm | 298.21 k shares | 0.94 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 7.85 mm | 312.59 k shares | 0.90 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 7.43 mm | 345.35 k shares | 0.85 | Common equity | Long | USA |
SYRE Spyre Therapeutics Inc. | 7.27 mm | 220.00 k shares | 0.83 | Common equity | Long | USA |
ABVX Abivax S.A. | 7.20 mm | 480.30 k shares | 0.82 | Common equity | Long | France |
Institutional Fiduciary Trust Money Market Portfolio | 7.06 mm | 7.06 mm shares | 0.81 | Short-term investment vehicle | Long | USA |
TMO Thermo Fisher Scientific Inc. | 6.98 mm | 12.28 k shares | 0.80 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 6.79 mm | 321.25 k shares | 0.78 | Common equity | Long | USA |
Oruka Therapeutics, Inc.
|
6.21 mm | 408.97 k shares | 0.71 | Common equity | Long | USA |
GH Guardant Health Inc | 5.82 mm | 323.37 k shares | 0.67 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 5.74 mm | 130.92 k shares | 0.66 | Common equity | Long | USA |
JSPR Jasper Therapeutics Inc | 5.65 mm | 236.84 k shares | 0.65 | Common equity | Long | USA |
KURA Kura Oncology Inc | 5.53 mm | 281.88 k shares | 0.63 | Common equity | Long | USA |
STTK Shattuck Labs Inc | 5.52 mm | 527.10 k shares | 0.63 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 5.39 mm | 1.49 mm shares | 0.62 | Common equity | Long | USA |
MLYS Mineralys Therapeutics Inc | 5.34 mm | 435.89 k shares | 0.61 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 5.34 mm | 122.03 k shares | 0.61 | Common equity | Long | Cayman Islands |
CGON Cg Oncology Inc. | 5.14 mm | 127.90 k shares | 0.59 | Common equity | Long | USA |
Contineum Therapeutics, Inc.
|
4.60 mm | 295.06 k shares | 0.53 | Common equity | Long | USA |
Applied Therapeutics, Inc.
|
4.46 mm | 1.01 mm shares | 0.51 | Common equity | Long | USA |
Engene Holdings, Inc.
|
4.33 mm | 272.36 k shares | 0.50 | Common equity | Long | Canada |
Crinetics Pharmaceuticals, Inc.
|
4.29 mm | 98.00 k shares | 0.49 | Common equity | Long | USA |
TERN Terns Pharmaceuticals Inc | 4.04 mm | 799.13 k shares | 0.46 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 3.96 mm | 57.55 k shares | 0.45 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 3.91 mm | 160.68 k shares | 0.45 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 3.80 mm | 93.36 k shares | 0.43 | Common equity | Long | Canada |
Roivant Sciences Ltd.
|
3.77 mm | 346.00 k shares | 0.43 | Common equity | Long | Bermuda |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 3.74 mm | 46.29 k shares | 0.43 | Common equity | Long | USA |
AURA Aura Biosciences Inc | 3.67 mm | 496.17 k shares | 0.42 | Common equity | Long | USA |
OCUL Ocular Therapeutix Inc | 3.56 mm | 750.10 k shares | 0.41 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 3.42 mm | 77.48 k shares | 0.39 | Common equity | Long | USA |
Adverum Biotechnologies, Inc.
|
3.42 mm | 351.93 k shares | 0.39 | Common equity | Long | USA |
CTNM Contineum Therapeutics Inc. - Ordinary Shares | 3.38 mm | 216.97 k shares | 0.39 | Common equity | Long | USA |
ANRO Alto Neuroscience Inc. | 3.25 mm | 209.50 k shares | 0.37 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 3.20 mm | 22.20 k shares | 0.37 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 3.19 mm | 80.83 k shares | 0.36 | Common equity | Long | Cayman Islands |
PLRX Pliant Therapeutics Inc | 3.19 mm | 269.60 k shares | 0.36 | Common equity | Long | USA |
BNTC Benitec Biopharma Inc | 3.08 mm | 364.89 k shares | 0.35 | Common equity | Long | USA |
AQST Aquestive Therapeutics Inc | 2.80 mm | 833.06 k shares | 0.32 | Common equity | Long | USA |
HRTX Heron Therapeutics Inc | 2.77 mm | 1.20 mm shares | 0.32 | Common equity | Long | USA |
PRAX Praxis Precision Medicines Inc | 2.77 mm | 50.40 k shares | 0.32 | Common equity | Long | USA |
Sartorius AG | 2.75 mm | 9.20 k shares | 0.31 | Preferred equity | Long | Germany |
RARE Ultragenyx Pharmaceutical Inc. | 2.69 mm | 63.32 k shares | 0.31 | Common equity | Long | USA |
ADVM Adverum Biotechnologies Inc | 2.65 mm | 272.81 k shares | 0.30 | Common equity | Long | USA |
Benitec Biopharma, Inc.
|
2.63 mm | 310.88 k shares | 0.30 | Common equity | Long | USA |
Alto Neuroscience, Inc.
|
2.56 mm | 165.07 k shares | 0.29 | Common equity | Long | USA |
Cogent Biosciences, Inc., Series B
|
2.21 mm | 340.45 k shares | 0.25 | Common equity | Long | USA |
Sartorius Stedim Biotech
|
2.18 mm | 10.10 k shares | 0.25 | Common equity | Long | France |
ABOS Acumen Pharmaceuticals Inc | 2.17 mm | 674.00 k shares | 0.25 | Common equity | Long | USA |
ETNB 89bio Inc | 2.16 mm | 254.24 k shares | 0.25 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals Inc | 2.07 mm | 234.00 k shares | 0.24 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 1.85 mm | 201.73 k shares | 0.21 | Common equity | Long | UK |
Lycia LLC, Series C
|
1.75 mm | 859.37 k shares | 0.20 | Common equity | Long | Japan |
CNTA Centessa Pharmaceuticals plc | 1.74 mm | 189.74 k shares | 0.20 | Common equity | Long | UK |
MRNS Marinus Pharmaceuticals Inc | 1.69 mm | 1.20 mm shares | 0.19 | Common equity | Long | USA |
BNTC Benitec Biopharma Inc | 1.68 mm | 7.02 mm shares | 0.19 | Long | Australia | |
ALEC Alector Inc | 1.54 mm | 303.35 k shares | 0.18 | Common equity | Long | USA |
Benitec Biopharma, Inc.
|
1.52 mm | 208.33 k shares | 0.17 | Common equity | Long | USA |
Benitec Biopharma, Inc.
|
1.45 mm | 310.88 k shares | 0.17 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 1.37 mm | 34.63 k shares | 0.16 | Common equity | Long | Cayman Islands |
SYRE Spyre Therapeutics Inc. | 1.16 mm | 35.10 k shares | 0.13 | Common equity | Long | USA |
KYTX Kyverna Therapeutics Inc. | 1.11 mm | 73.60 k shares | 0.13 | Common equity | Long | USA |
RLMD Relmada Therapeutics Inc | 1.00 mm | 275.70 k shares | 0.11 | Common equity | Long | USA |
Artiva Biotherapeutics, Inc., Class B
|
946.20 k | 189.50 k shares | 0.11 | Common equity | Long | USA |
Achieve Life Sciences, Inc.
|
863.88 k | 2.18 mm shares | 0.10 | Common equity | Long | USA |
MGNX Macrogenics Inc | 755.26 k | 51.10 k shares | 0.09 | Common equity | Long | USA |
Carmot Therapeutics, Inc.
|
401.34 k | 83.10 k shares | 0.05 | Common equity | Long | USA |
SLRN Acelyrin Inc | 290.13 k | 69.41 k shares | 0.03 | Common equity | Long | USA |
NUVB Nuvation Bio Inc - Ordinary Shares | 21.04 k | 115.27 k shares | 0.00 | Long | USA | |
Sanofi SA, Escrow Account
|
0 | 2.33 mm shares | 0.00 | Common equity | Long | Colombia |